Ignite Creation Date:
2025-12-25 @ 2:23 AM
Ignite Modification Date:
2026-02-28 @ 9:30 PM
Study NCT ID:
NCT04448834
Status:
WITHDRAWN
Last Update Posted:
2022-03-02
First Post:
2020-06-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Blincyto Amgen Acrotech BioPharma PH2 Blincyto Marqibo R/R Philadelphi CD19+ ALL
Sponsor:
Dorothy Sipkins, MD, PhD
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | B-cell Acute Lymphoblastic Leukemia | View |
Keywords: